|
Symbol
|
RMA0EV | RMA72V | RMBMQV | OZYRCH | ABDSTQ | ABEUTQ | RMBM8V | ABEFTQ | RMASDV | ABWQSQ | CHLBKB | ABITTQ | RMBQ3V | RMBQ5V | PEYRCH | CGJBKB | PGJRCH | RMBHUV | ABJTTQ | ABNSTQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Barrier Reverse Convertible | Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Worst of Reverse Convertible | Barrier Reverse Convertible | Worst of Reverse Convertible | Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible |
|
Sous-jacent
|
Novo Nordisk AS (B) / Ypsomed Hldg. AG | Novartis AG / Roche AG / Sandoz Group AG / Ypsomed Hldg. AG | Bachem Hldg. AG / Straumann Hldg. AG / Ypsomed Hldg. AG | Bachem Hldg. AG / Lonza Group N / Ypsomed Hldg. AG | Sandoz Group AG / Straumann Hldg. AG / Ypsomed Hldg. AG | Lonza Group N / Sonova Hldg. AG / Ypsomed Hldg. AG | Lonza Group N / Straumann Hldg. AG / Ypsomed Hldg. AG | Lonza Group N / Straumann Hldg. AG / Ypsomed Hldg. AG | Galderma Group AG / Givaudan / Ypsomed Hldg. AG | Roche AG / Sonova Hldg. AG / Ypsomed Hldg. AG | Bachem Hldg. AG / Lonza Group N / Ypsomed Hldg. AG | Lonza Group N / Straumann Hldg. AG / Ypsomed Hldg. AG | Helvetia Baloise Holding AG / Ypsomed Hldg. AG / Sandoz Group AG | Eli Lilly & Co. / Novo Nordisk AS (B) / Roche AG / Ypsomed Hldg. AG | Bachem Hldg. AG / Sandoz Group AG / Ypsomed Hldg. AG | Nestlé S.A. / Novartis AG / Roche AG / Ypsomed Hldg. AG | Sonova Hldg. AG / Straumann Hldg. AG / Ypsomed Hldg. AG | Alcon / Roche AG / Siegfried Hldg. AG / Ypsomed Hldg. AG | Lonza Group N / Straumann Hldg. AG / Ypsomed Hldg. AG | Bachem Hldg. AG / Lonza Group N / Straumann Hldg. AG / Ypsomed Hldg. AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
15.06.2026 | 31.08.2026 | 27.03.2026 | 14.04.2026 | 09.04.2026 | 15.04.2026 | 27.04.2026 | 15.04.2026 | 11.05.2026 | 08.05.2026 | 11.05.2026 | 06.05.2026 | 18.05.2026 | 17.11.2026 | 18.05.2026 | 05.05.2026 | 22.05.2026 | 01.06.2026 | 12.05.2026 | 26.05.2026 |
| Demande | 31,500 | 76,80 | 95,60 | 74,03 | 69,43 | 74,32 | 97,80 | 72,29 | 83,70 | 63,07 | 99,16 | 92,22 | 94,00 | 44,500 | 73,33 | 96,40 | 72,41 | 71,30 | 74,96 | 95,69 |
| Offre | - | - | - | - | - | - | 98,60 | - | - | - | 99,96 | - | - | - | - | - | - | - | - | - |